russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-2302Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWМЕЛКИЕ ПЛОТНЫЕ СУБФРАКЦИИ ЛИПОПРОТЕИНОВ НИЗКОЙ ПЛОТНОСТИ И АТЕРОГЕНЕЗSmall dense subfractions of low-density lipoproteins and atherogenesisРагиноЮ. И.RaginoYu. I.Научно-исследовательский институт терапии СО РАМНРоссия200428082004048490Copyright © Рагино Ю.И., 20042004Рагино Ю.И.Ragino Y.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/2302
.
.
ReferencesAbate N., Vega G.L., Garg A. et al. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM//Atherosclerosis. 1995; 118: 111-122.Abate N., Vega G.L., Garg A. et al. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM//Atherosclerosis. 1995; 118: 111-122.Anber V., Griffin B.D., Packard C.J., Shepherd J. Preferential binding of small, dense LDL to human arterial proteoglycan//Atherosclerosis. 1994; 109: 217-226.Anber V., Griffin B.D., Packard C.J., Shepherd J. Preferential binding of small, dense LDL to human arterial proteoglycan//Atherosclerosis. 1994; 109: 217-226.Austin M.A, King M., Vranizan K.M. and Krauss R.M. Atherogenic lipoprotein phenotype A proposed genetic marker for coronary heart disease risk//Circulation. 1990; 82: 495-506.Austin M.A, King M., Vranizan K.M. and Krauss R.M. Atherogenic lipoprotein phenotype A proposed genetic marker for coronary heart disease risk//Circulation. 1990; 82: 495-506.Austin M.A., Selby J.V. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome//Intern. J. Obesity. 1995; 19: 522-526.Austin M.A., Selby J.V. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome//Intern. J. Obesity. 1995; 19: 522-526.Beard С.М., Barnard R.J., Robbins D.C. et al. Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation//Arterioscler. Thrombosis and Vascular Biology. 1996; 16: 201-207.Beard С.М., Barnard R.J., Robbins D.C. et al. Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation//Arterioscler. Thrombosis and Vascular Biology. 1996; 16: 201-207.Betteridge D.J. Lipids and atherogenesis in diabetes mellitus//Atherosclerosis. 1996; 124: 543-547.Betteridge D.J. Lipids and atherogenesis in diabetes mellitus//Atherosclerosis. 1996; 124: 543-547.Capell W.H., Zambon A., Austin M.A. et al. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype В//Arterioscler. Thrombosis and Vascular Biology. 1996; 16: 1040-1046.Capell W.H., Zambon A., Austin M.A. et al. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype В//Arterioscler. Thrombosis and Vascular Biology. 1996; 16: 1040-1046.Caslake M.J., Packard C.J., Gaw A. et al. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia//Arterioscler. Thrombosis and Vascular Biology. 1993; 13: 702-713.Caslake M.J., Packard C.J., Gaw A. et al. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia//Arterioscler. Thrombosis and Vascular Biology. 1993; 13: 702-713.Chapman M.J., Bruckert E. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy//Atherosclerosis. 1996; 124: 921-928.Chapman M.J., Bruckert E. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy//Atherosclerosis. 1996; 124: 921-928.Chapman M.J., Guerin M., Bruckert E. Atherogenic, dense LDL pathophysiology and new therapeutic approaches//Eur. Heart J. 1998; 19: 24-30.Chapman M.J., Guerin M., Bruckert E. Atherogenic, dense LDL pathophysiology and new therapeutic approaches//Eur. Heart J. 1998; 19: 24-30.Chapman M.J. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives//Atherosclerosis. 2003; 171: 1-13.Chapman M.J. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives//Atherosclerosis. 2003; 171: 1-13.Chappey В., Myara I., Benoit M.O. et al. Characteristics of ten charge-differing subtractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications//Biochim. et Biophysica Acta 1995; 1259: 261-270.Chappey В., Myara I., Benoit M.O. et al. Characteristics of ten charge-differing subtractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications//Biochim. et Biophysica Acta 1995; 1259: 261-270.De Graaf J., Hak-Lemmers H.L.M., Hectors M.P.S. et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subtraction in healthy subjects//Arterioscler. Thrombosis and Vascular Biology. 1991; 11: 2988-306.De Graaf J., Hak-Lemmers H.L.M., Hectors M.P.S. et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subtraction in healthy subjects//Arterioscler. Thrombosis and Vascular Biology. 1991; 11: 2988-306.De Graaf J., Demacker P.N.M., Stalenhoef AF.H. LDL oxidation and coronary atherosclerosis//Lancet. 1992; 340: 123-124.De Graaf J., Demacker P.N.M., Stalenhoef AF.H. LDL oxidation and coronary atherosclerosis//Lancet. 1992; 340: 123-124.Dejager S., Bruckert E., Chapman M.J. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia//J. Lipid Research. 1993; 34: 295-308.Dejager S., Bruckert E., Chapman M.J. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia//J. Lipid Research. 1993; 34: 295-308.Dejager S., Turbin G. Low-density lipoproteins and atherosclerosis -A problem of quantity or quality?//Press Medicale. 1995; 24: 1772-1776.Dejager S., Turbin G. Low-density lipoproteins and atherosclerosis -A problem of quantity or quality?//Press Medicale. 1995; 24: 1772-1776.Destypere J.P. Modified lipoproteins in diabetes//J. Intern. Med. 1994; 236: 69-74.Destypere J.P. Modified lipoproteins in diabetes//J. Intern. Med. 1994; 236: 69-74.Esterbauer H. and Jurgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation//Curr. Opin. in Lipidol. 1993; 4: 114-124.Esterbauer H. and Jurgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation//Curr. Opin. in Lipidol. 1993; 4: 114-124.Fainaru M., Gavish D., Schafer Z. Diurnal heterogeneity in structure and function of low density lipoproteins of normolipidemic males//J. Medical Sciences. 1996; 32: 454-464.Fainaru M., Gavish D., Schafer Z. Diurnal heterogeneity in structure and function of low density lipoproteins of normolipidemic males//J. Medical Sciences. 1996; 32: 454-464.Frost R.J.A., Otto C., Geiss H.C. et al. Effects of atorvastatin vs. fenofibrate on lipoproteins, LDL subfraction distribution and hemorheology in type 2 diabetic patients with mixed hyperlipoproteinemia//Atherosclerosis. 2000; 151: 13.Frost R.J.A., Otto C., Geiss H.C. et al. Effects of atorvastatin vs. fenofibrate on lipoproteins, LDL subfraction distribution and hemorheology in type 2 diabetic patients with mixed hyperlipoproteinemia//Atherosclerosis. 2000; 151: 13.Geiss H.C., Parhofer K.G., Schwandt P. Influence of simvastatin on LDL subtypes in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia//Atherosclerosis. 2000; 151:36.Geiss H.C., Parhofer K.G., Schwandt P. Influence of simvastatin on LDL subtypes in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia//Atherosclerosis. 2000; 151:36.Griffin B.A, Freeman D.J., Tait G.W. et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein subtractions: relative contribution of small, dense LDL to coronary heart disease risk//Atherosclerosis. 1994; 106: 241-251.Griffin B.A, Freeman D.J., Tait G.W. et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein subtractions: relative contribution of small, dense LDL to coronary heart disease risk//Atherosclerosis. 1994; 106: 241-251.Halle M., Berg A., Frey I. et al. Relationship between obesity and concentration and composition of low-density lipoprotein subtractions in normoinsulinemic men//Metabol. Clinical and Experimental. 1995; 44: 1384-1390.Halle M., Berg A., Frey I. et al. Relationship between obesity and concentration and composition of low-density lipoprotein subtractions in normoinsulinemic men//Metabol. Clinical and Experimental. 1995; 44: 1384-1390.Kornitzer M., Dramaix M., Vanderbroek M.D. et al. Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study//Atherosclerosis. 1994; 110 (Suppl.): S49-S54.Kornitzer M., Dramaix M., Vanderbroek M.D. et al. Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study//Atherosclerosis. 1994; 110 (Suppl.): S49-S54.Krauss R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk//Curr. Opin. Lipidol. 1994; 5: 339-348.Krauss R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk//Curr. Opin. Lipidol. 1994; 5: 339-348.Krauss R.M., Stampfer M.J., Blanche P.J. et al. A prospective study of LDL particle diameter and risk of myocardial infarction//Circulation. 1994; 90: 460-469.Krauss R.M., Stampfer M.J., Blanche P.J. et al. A prospective study of LDL particle diameter and risk of myocardial infarction//Circulation. 1994; 90: 460-469.Krauss R.M., Rotter J.I., Lusis A.J. Genetic and metabolic influences on LDL subclasses//Atherosclerosis X. 1995; 980-983.Krauss R.M., Rotter J.I., Lusis A.J. Genetic and metabolic influences on LDL subclasses//Atherosclerosis X. 1995; 980-983.Liu M.L., Ylitalo K., Valkonen M. et al. Relationship between susceptibility of LDL to oxidation in vitro and LDL size in FCHL patients//Atherosclerosis. 2000; 151: 262.Liu M.L., Ylitalo K., Valkonen M. et al. Relationship between susceptibility of LDL to oxidation in vitro and LDL size in FCHL patients//Atherosclerosis. 2000; 151: 262.McKenney J., McCormick L. The effect of atorvastatin and niacin on lipoprotein subclasses in patients with mixed hyperlipidemia//Atherosclerosis XL 1997; 134: 98-115.McKenney J., McCormick L. The effect of atorvastatin and niacin on lipoprotein subclasses in patients with mixed hyperlipidemia//Atherosclerosis XL 1997; 134: 98-115.Nigon F., Lesnik P., Rouis M. et al. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor//J. Lipid Res. 1991; 32: 1741-1753.Nigon F., Lesnik P., Rouis M. et al. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor//J. Lipid Res. 1991; 32: 1741-1753.Nikkila M., Pitkajarvi T., Koivula T. et al. Women have a larger and less atherogenic low density lipoprotein particle size than men//Atherosclerosis. 1996; 119: 181-190.Nikkila M., Pitkajarvi T., Koivula T. et al. Women have a larger and less atherogenic low density lipoprotein particle size than men//Atherosclerosis. 1996; 119: 181-190.Otvos J., Jeyarajah E., Ordovas J. et al. Lipoprotein subclasses measured by NMR spectroscopy help explain the sex differential in coronary artery disease. Results from the Framingham Offspring Study//Atherosclerosis. 2000; 151: 128.Otvos J., Jeyarajah E., Ordovas J. et al. Lipoprotein subclasses measured by NMR spectroscopy help explain the sex differential in coronary artery disease. Results from the Framingham Offspring Study//Atherosclerosis. 2000; 151: 128.Patti L., Dimarino L., Maffettone A. et al. Very low density lipoprotein subtraction abnormalities in IDDM patients: any effect of blood glucose control?//Diabetologia 1995; 38: 1419-1424.Patti L., Dimarino L., Maffettone A. et al. Very low density lipoprotein subtraction abnormalities in IDDM patients: any effect of blood glucose control?//Diabetologia 1995; 38: 1419-1424.Rajman I., Kendall M.J., Cramb R. et al. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men//Atherosclerosis. 1996; 125: 231-242.Rajman I., Kendall M.J., Cramb R. et al. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men//Atherosclerosis. 1996; 125: 231-242.Rosenson R.S., Otvos J.D., Freedman D.S. Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC-I trial//Am. J. Cardiol. 2002; 90: 89-94.Rosenson R.S., Otvos J.D., Freedman D.S. Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC-I trial//Am. J. Cardiol. 2002; 90: 89-94.Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime//Nature Medicine. 2002; 8: 1211-1218.Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime//Nature Medicine. 2002; 8: 1211-1218.Tan C.E., Forster L., Caslake M.J. et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subtraction patterns in normolipidemic men and women//Arterioscler. Thrombosis and Vascular Biology. 1995; 15: 1839-1848.Tan C.E., Forster L., Caslake M.J. et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subtraction patterns in normolipidemic men and women//Arterioscler. Thrombosis and Vascular Biology. 1995; 15: 1839-1848.Tribble D.L., Holl L.G., Wood P.D. et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size//Atherosclerosis. 1992; 93: 189-199.Tribble D.L., Holl L.G., Wood P.D. et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size//Atherosclerosis. 1992; 93: 189-199.Tribble D.L., Krauss R.M., Lansberg M.G. et al. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions//J. Lipid Research. 1995; 36: 662-671.Tribble D.L., Krauss R.M., Lansberg M.G. et al. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions//J. Lipid Research. 1995; 36: 662-671.Wlliams P.T., Dreon D.M., Krauss R.M. Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns//Am. J. Clinic. Nutrition. 1995; 61: 1234-1240.Wlliams P.T., Dreon D.M., Krauss R.M. Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns//Am. J. Clinic. Nutrition. 1995; 61: 1234-1240.
The authors declare that there are no conflicts of interest present.